Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osigraft in instrumented posterolateral lumbar fusion
2004-000675-34Phase 3Active
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bone morphogenetic protein 7 in degenerative disc disease (DDD) and spondylolisthesis (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Overall success rate at 12 months, Safety and 1 more. Started Nov 2005; status: active.
02
Drugs
bone morphogenetic protein 7
03
Conditions
degenerative disc disease (DDD)spondylolisthesis
Beyond the preview
Go deeper on 2004-000675-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000675-34.